http://acidophil.com/ 1.00 http://acidophil.com/about/ 0.80 http://acidophil.com/management-board-key-investors/ 0.80 http://acidophil.com/innovation-partners/ 0.80 http://acidophil.com/analystinternship-program/ 0.80 http://acidophil.com/approach/ 0.80 http://acidophil.com/track-record/ 0.80 http://acidophil.com/news/ 0.80 http://acidophil.com/contact-us/ 0.80 http://acidophil.com/current-focus/ 0.80 http://acidophil.com/pgt-sells-part-of-its-patent-portfolio-to-agilent/ 0.80 http://acidophil.com/category/current-focus/ 0.64 http://acidophil.com/category/current-news/ 0.64 http://acidophil.com/category/archived-news/ 0.64 http://acidophil.com/agrimetis-raises-23-5m-series-b-for-natural-products-derived-crop-protection-research/ 0.64 http://acidophil.com/agrimetis-a-nimble-research-approach-nets-new-crop-protection-chemicals/ 0.64 http://acidophil.com/biosyntha-and-zuvachem-announce-a-merger-and-financing-to-form-zuvasyntha-ltd/ 0.64 http://acidophil.com/arginetix-and-immune-control-merge-to-form-corridor-pharmaceuticals/ 0.64